Glenn E. Matroos

699 total citations
17 papers, 475 citations indexed

About

Glenn E. Matroos is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Glenn E. Matroos has authored 17 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 13 papers in Psychiatry and Mental health and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Glenn E. Matroos's work include Schizophrenia research and treatment (12 papers), Parkinson's Disease Mechanisms and Treatments (11 papers) and Neurological disorders and treatments (9 papers). Glenn E. Matroos is often cited by papers focused on Schizophrenia research and treatment (12 papers), Parkinson's Disease Mechanisms and Treatments (11 papers) and Neurological disorders and treatments (9 papers). Glenn E. Matroos collaborates with scholars based in Netherlands, Curacao and United States. Glenn E. Matroos's co-authors include Hans W. Hoek, Peter N. van Harten, René S. Kahn, Jim van Os, Peter N. van Harten, Maarten W.J. Koeter, Melanie A. Katzman, Ezra Susser, D.J. Kamphuis and Bob Wilffert and has published in prestigious journals such as American Journal of Psychiatry, Schizophrenia Bulletin and Schizophrenia Research.

In The Last Decade

Glenn E. Matroos

16 papers receiving 450 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glenn E. Matroos Netherlands 12 271 244 98 70 36 17 475
A. Topitz Austria 8 137 0.5× 83 0.3× 75 0.8× 92 1.3× 8 0.2× 18 374
M. A. Dalby Denmark 12 146 0.5× 78 0.3× 39 0.4× 73 1.0× 26 0.7× 17 423
Mercedes Zumárraga Spain 12 154 0.6× 33 0.1× 52 0.5× 64 0.9× 24 0.7× 33 345
L Peacock Denmark 8 215 0.8× 73 0.3× 29 0.3× 83 1.2× 16 0.4× 12 338
Val Sharkey United Kingdom 7 245 0.9× 39 0.2× 71 0.7× 31 0.4× 69 1.9× 10 394
Siddhartha Nadkarni United States 8 207 0.8× 65 0.3× 24 0.2× 81 1.2× 22 0.6× 11 341
WW Fleischhacker Austria 4 92 0.3× 87 0.4× 26 0.3× 110 1.6× 9 0.3× 7 321
Mirjam van Tricht Netherlands 6 132 0.5× 50 0.2× 31 0.3× 48 0.7× 12 0.3× 9 285
Kenji Tagai Japan 12 139 0.5× 93 0.4× 38 0.4× 52 0.7× 7 0.2× 50 325
Mariluz Ramírez-Bonilla Spain 10 446 1.6× 34 0.1× 112 1.1× 25 0.4× 24 0.7× 11 534

Countries citing papers authored by Glenn E. Matroos

Since Specialization
Citations

This map shows the geographic impact of Glenn E. Matroos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn E. Matroos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn E. Matroos more than expected).

Fields of papers citing papers by Glenn E. Matroos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn E. Matroos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn E. Matroos. The network helps show where Glenn E. Matroos may publish in the future.

Co-authorship network of co-authors of Glenn E. Matroos

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn E. Matroos. A scholar is included among the top collaborators of Glenn E. Matroos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn E. Matroos. Glenn E. Matroos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bakker, P. Roberto, Jim van Os, Diederik E. Tenback, et al.. (2022). Movement Disorders and Mortality in Severely Mentally Ill Patients: The Curacao Extrapyramidal Syndromes Study XIV. Schizophrenia Bulletin. 48(4). 766–773. 1 indexed citations
2.
Bakker, P. Roberto, Jim van Os, Marjan Drukker, et al.. (2017). Effect of Antipsychotic Type and Dose Changes on Tardive Dyskinesia and Parkinsonism Severity in Patients With a Serious Mental Illness. The Journal of Clinical Psychiatry. 78(3). e279–e285. 29 indexed citations
3.
Bakker, P. Roberto, Jim van Os, Marjan Drukker, et al.. (2017). Blink rate is associated with drug-induced parkinsonism in patients with severe mental illness, but does not meet requirements to serve as a clinical test: the Curacao extrapyramidal syndromes study XIII. Journal of Negative Results in BioMedicine. 16(1). 15–15. 3 indexed citations
4.
Wilffert, Bob, Richard Bruggeman, Roy E. Stewart, et al.. (2009). Lack of association between antipsychotic‐induced Parkinsonism or its subsymptoms and rs4606 SNP of RGS2 gene in African‐Caribbeans and the possible role of the medication: The Curacao extrapyramidal syndromes study X. Human Psychopharmacology Clinical and Experimental. 24(2). 123–128. 24 indexed citations
5.
Wilffert, Bob, Roy E. Stewart, Richard Bruggeman, et al.. (2008). Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African‐Caribbean inpatients: Differences in association with dopamine and serotonin receptors. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 147B(6). 890–897. 30 indexed citations
6.
Wilffert, Bob, Glenn E. Matroos, Hans W. Hoek, et al.. (2008). The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment. Journal of Psychopharmacology. 23(6). 652–659. 35 indexed citations
7.
Harten, Peter N. van, Hans W. Hoek, Glenn E. Matroos, & Jim van Os. (2007). Evidence that lithium protects against tardive dyskinesia: The Curaçao Extrapyramidal Syndromes study VI. European Neuropsychopharmacology. 18(2). 152–155. 15 indexed citations
8.
Harten, Peter N. van, Glenn E. Matroos, & Jim van Os. (2007). The course of tardive dystonia in Afro Caribbean patients, a population-based study. Schizophrenia Research. 98(1-3). 79–83. 10 indexed citations
9.
Harten, Peter N. van, Hans W. Hoek, Glenn E. Matroos, & Jim van Os. (2006). Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment:The Curacao Extrapyramidal Syndromes Study V. University of Groningen research database (University of Groningen / Centre for Information Technology).
10.
Harten, Peter N. van, Hans W. Hoek, Glenn E. Matroos, & Jim van Os. (2006). Incidence of Tardive Dyskinesia and Tardive Dystonia in African Caribbean Patients on Long-Term Antipsychotic Treatment. The Journal of Clinical Psychiatry. 67(12). 1920–1927. 25 indexed citations
11.
Hoek, Hans W., et al.. (2005). The Incidence of Anorexia Nervosa on Curaçao. American Journal of Psychiatry. 162(4). 748–752. 71 indexed citations
12.
Harten, Peter N. van, Glenn E. Matroos, Hans W. Hoek, & René S. Kahn. (2000). Movement disorders associated with neuroleptics. The curaçao extrapyramidal syndromes study: I–III. Schizophrenia Research. 41(1). 262–262. 3 indexed citations
13.
Harten, Peter N. van, Hans W. Hoek, Glenn E. Matroos, Maarten W.J. Koeter, & René S. Kahn. (1998). Intermittent Neuroleptic Treatment and Risk for Tardive Dyskinesia: Curaçao Extrapyramidal Syndromes Study III. American Journal of Psychiatry. 155(4). 565–567. 49 indexed citations
14.
Harten, Peter N. van, et al.. (1998). Cocaine as a Risk Factor for Neuroleptic-Induced Acute Dystonia. The Journal of Clinical Psychiatry. 59(3). 128–130. 34 indexed citations
15.
Harten, Peter N. van, Hans W. Hoek, Glenn E. Matroos, Maarten W.J. Koeter, & René S. Kahn. (1997). The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II. Schizophrenia Research. 26(2-3). 235–242. 28 indexed citations
16.
Harten, Peter N. van, Glenn E. Matroos, Hans W. Hoek, & René S. Kahn. (1996). The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao extrapyramidal syndromes study: I. Schizophrenia Research. 19(2-3). 195–203. 83 indexed citations
17.
Harten, Peter N. van, D.J. Kamphuis, & Glenn E. Matroos. (1996). Use of clozapine in tardive dystonia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 20(2). 263–274. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Topitz Breakdown of academic impact, for papers by M. A. Dalby Breakdown of academic impact, for papers by Mercedes Zumárraga Breakdown of academic impact, for papers by L Peacock Breakdown of academic impact, for papers by Val Sharkey Breakdown of academic impact, for papers by Siddhartha Nadkarni Breakdown of academic impact, for papers by WW Fleischhacker Breakdown of academic impact, for papers by Mirjam van Tricht Breakdown of academic impact, for papers by Kenji Tagai Breakdown of academic impact, for papers by Mariluz Ramírez-Bonilla
Rankless by CCL
2026